URAT1 inhibition in hyperuricemia and gout: from transporter biology to clinical precision therapy

作者
Guangtao Li,Yu Wang,Zhuoli Zhang
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:17: 1915148-1915148
标识
DOI:10.3389/fimmu.2026.1915148
摘要

Impaired renal urate excretion is a major mechanism underlying hyperuricemia and gout, with urate transporter 1 (URAT1), encoded by SLC22A12, playing a central role in proximal tubular urate reabsorption. This review summarizes the biological relevance of URAT1, the pharmacological evolution of URAT1 inhibitors, and their clinical implications in urate-lowering therapy. Evidence from transporter biology, structural pharmacology, pharmacokinetic and pharmacodynamic studies, and clinical trials was narratively synthesized. URAT1 inhibitors lower serum urate by blocking renal tubular urate reabsorption and increasing urinary urate excretion, providing a mechanism complementary to xanthine oxidase inhibition. Early uricosuric agents established the clinical value of this approach but are limited by non-selective transporter inhibition, tolerability concerns, drug-drug interactions, and organ-specific safety issues. Newer selective URAT1 inhibitors have been developed to improve transporter selectivity, pharmacodynamic precision, and clinical usability. Current evidence supports selective URAT1 inhibition as an effective strategy for achieving serum urate targets, particularly in underexcretion-type hyperuricemia, while renal monitoring and prevention of uric acid stone formation remain important. Emerging agents may further expand treatment options, but long-term renal, hepatic, and cardiovascular safety require further validation. Overall, URAT1 inhibition represents a rational and increasingly precise therapeutic strategy for hyperuricemia and gout, with future research needed to define its long-term outcomes, comparative effectiveness, pharmacogenomic predictors, and broader cardio-renal-metabolic implications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
工藤新一完成签到,获得积分10
刚刚
elelelelelelel完成签到 ,获得积分10
刚刚
刚刚
yj发布了新的文献求助10
1秒前
Ann发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
3秒前
3秒前
3秒前
Humingyu发布了新的文献求助10
4秒前
mayunrou3759完成签到 ,获得积分10
4秒前
Maestro_S的应助被青争采纳,获得10
4秒前
坦率的萝莉完成签到 ,获得积分10
5秒前
Eliauk完成签到,获得积分10
5秒前
5秒前
6秒前
ppf发布了新的文献求助10
6秒前
纯真的凝安完成签到,获得积分10
6秒前
6秒前
yangz发布了新的文献求助10
7秒前
8秒前
大个的应助被王小鸿鸿鸿鸿采纳,获得10
8秒前
清新完成签到,获得积分10
8秒前
Artorias完成签到,获得积分10
8秒前
顺利的招牌完成签到,获得积分10
9秒前
9秒前
YOYO完成签到,获得积分20
9秒前
orixero的应助被Qin采纳,获得30
9秒前
10秒前
10秒前
漫漫发布了新的文献求助10
10秒前
简单大地发布了新的文献求助10
11秒前
123发布了新的文献求助10
11秒前
11秒前
yangz完成签到,获得积分10
11秒前
陈念完成签到,获得积分10
11秒前
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181279
求助须知:如何正确求助?哪些是违规求助? 9571198
关于积分的说明 21817073
捐赠科研通 7777612
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479519